Trial intelligence / Profile preview

Effectiveness of Artemisia absinthium on sexual performance and satisfaction in women

IRCT20210223050471N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Apr 2021
Modality
Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3 trial of artemisia absinthium pollen extract in female sexual dysfunction (FSD) and None, sponsored by Mashhad University of Medical Sciences. Started Apr 2021; status: completed.

02

Drugs

artemisia absinthium pollen extract
03

Conditions

female sexual dysfunction (FSD)

Beyond the preview

Go deeper on IRCT20210223050471N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210223050471N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call